CTS Announces Second Quarter 2024 Results

by

in

LISLE, Ill., July 30, 2024 (GLOBE NEWSWIRE) — CTS Corporation (NYSE:CTS), a leading global designer and manufacturer of custom engineered solutions that “Sense, Connect and Move,” today announced second quarter 2024 results.

“We achieved earnings in line with our expectations, despite softness in the transportation end market. We made progress on operational improvements, which helped partially offset the unfavorable impact from lower volumes.” said Kieran O’Sullivan, CEO of CTS Corporation. “Our team is energized on future growth through continued diversification of our customer base and building our pipeline of opportunities. We remain committed to a disciplined capital structure to support organic growth, strategic acquisitions and returning cash to shareholders.”

CTS completed the acquisition of SyQwest, LLC on July 29, 2024 for $125 million, net of cash and debt, and contingent consideration. SyQwest is a leading designer and manufacturer of a broad set of sonar and acoustic sensing solutions primarily for naval applications. “SyQwest adds strong technical capabilities and enhances our scale in underwater acoustic applications in the defense end market, further advancing our diversification strategy,” said Kieran O’Sullivan. “We are excited about the growth momentum and welcome Bob Tarini and the SyQwest team to CTS.”

Second Quarter 2024 Results

Sales were $130 million, up 4% sequentially compared to the first quarter of 2024, and down 10% year-over-year. Sales to non-transportation end markets increased 11% sequentially and 4% year-over-year. Sales to the transportation end market decreased 3% sequentially and 22% year-over-year.
Net income was $15 million, or 11% of sales, up from $13 million, or 9% of sales, in the second quarter of 2023.
Earnings per diluted share were $0.48, compared to $0.41 in the second quarter of 2023.
Adjusted earnings per diluted share were $0.54, down from $0.59 in the second quarter of 2023.
Adjusted EBITDA margin was 21.7%, compared to 21.3% in the second quarter of 2023.
Operating cash flow was $20 million, down from $23 million in the second quarter of 2023.

2024 Guidance

Given the more moderate growth expectations in the second half of 2024, CTS is updating its guidance for full year 2024 sales to be in the range of $525 – $540 million and adjusted diluted EPS to be in the range of $2.05 – $2.25, including the expected impact from the SyQwest acquisition.

CTS does not provide reconciliations of forward-looking non-GAAP financial measures, such as estimated adjusted diluted earnings per share, to the most comparable GAAP financial measures on a forward-looking basis because CTS is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition-related costs, foreign exchange rates and other non-routine costs. Each of such adjustments has not yet occurred, are out of CTS’ control and/or cannot be reasonably predicted. For the same reasons, CTS is unable to address the probable significance of the unavailable information.

Conference Call and Supplemental Materials
As previously announced, the Company has scheduled a conference call for 10:00 a.m. (ET) today. The dial-in numbers for access from the U.S. are: +1-833-470-1428 (Toll-Free) and +1-404-975-4839 (Local), if calling from outside the U.S., please refer to Global Dial In Numbers to identify the applicable dial-in number for your location. The passcode is 325452. In addition, the Company will be using a supplemental slide presentation that will be referred to during the call. The presentation and a live audio webcast of the conference call will be available and can be accessed directly from CTS’ website at https://investors.ctscorp.com/news-events/events-and-presentations/.

Any replay, rebroadcast, transcript or other reproduction or transmission of this conference call, other than the replay accessible through the website noted above, has not been authorized by the Company and is strictly prohibited. Investors should be aware that any unauthorized reproduction of this conference call may not be an accurate reflection of its contents.

About CTS

CTS Corporation (NYSE:CTS) is a leading designer and manufacturer of products that Sense, Connect and Move. CTS manufactures sensors, actuators and electronic components in North America, Europe and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical and transportation markets. For more information, visit www.ctscorp.com
  
Cautionary Statement Regarding Forward-Looking Statements

Readers are cautioned that the statements contained in this document regarding expectations of our performance or other matters that may affect our business, results of operations, or financial condition are, or may be deemed to be, “forward-looking statements” as defined by the “safe harbor” provisions in the Private Securities Litigation Reform Act of 1995. Such statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, included or incorporated in this document, including statements regarding our strategy, financial position, guidance, funding for continued operations, cash reserves, liquidity, projected costs, plans, projects, awards and contracts, and objectives of management, among others, are forward-looking statements. Words such as “expect,” “anticipate,” “should,” “believe,” “hope,” “target,” “continued,” “project,” “plan,” “goals,” “opportunity,” “appeal,” “estimate,” “potential,” “predict,” “demonstrates,” “may,” “will,” “might,” “could,” “intend,” “shall,” “possible,” “would,” “approximately,” “likely,” “outlook,” “schedule,” “on track,” “poised,” “pipeline,” and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements are not guarantees of future performance, conditions or results. Forward-looking statements are based on management’s expectations, certain assumptions, and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties, and other factors, which could cause CTS’ actual results, performance, or achievements to differ materially from those presented in the forward-looking statements. Examples of factors that may affect future operating results and financial condition include, but are not limited to: supply chain disruptions; changes in the economy generally, including inflationary and/or recessionary conditions, and in respect to the business in which CTS operates; unanticipated issues in integrating acquisitions, including, without limitation, the integration of SyQwest, LLC; the results of actions to reposition CTS’ business; rapid technological change; general market conditions in the transportation, as well as conditions in the industrial, aerospace and defense, and medical markets; reliance on key customers; unanticipated public health crises, natural disasters or other events; environmental compliance and remediation expenses; the ability to protect CTS’ intellectual property; pricing pressures and demand for CTS’ products; risks associated with CTS’ international operations, including trade and tariff barriers, exchange rates and political and geopolitical risks (including, without limitation, the potential impact U.S./China relations and the conflict between Russia and Ukraine may have on our business, results of operations and financial condition); the amount and timing of any share repurchases; and the effect of any cybersecurity incidents on our business. Many of these, and other risks and uncertainties, are discussed in further detail in Item 1A. of CTS’ most recent Annual Report on Form 10-K and other filings made with the SEC. CTS undertakes no obligation to publicly update CTS’ forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes. 

Contact
Ashish Agrawal
Vice President and Chief Financial Officer
CTS Corporation
4925 Indiana Avenue
Lisle, IL 60532 USA
+1 (630) 577-8800
ashish.agrawal@ctscorp.com

CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OFEARNINGS– UNAUDITED
(In thousands, except per share amounts)
 

 
 

 
 
Three Months Ended
 
 
Six Months Ended
 

 
 
June 30,
2024
 
 
June 30,
2023
 
 
June 30,
2024
 
 
June 30,
2023
 

Net sales
 
$
130,162
 
 
$
145,182
 
 
$
255,912
 
 
$
291,176
 

Cost of goods sold
 
 
83,790
 
 
 
94,440
 
 
 
164,450
 
 
 
188,782
 

Gross margin
 
 
46,372
 
 
 
50,742
 
 
 
91,462
 
 
 
102,394
 

Selling, general and administrative expenses
 
 
21,332
 
 
 
23,694
 
 
 
43,591
 
 
 
45,673
 

Research and development expenses
 
 
6,086
 
 
 
6,721
 
 
 
12,687
 
 
 
13,307
 

Restructuring charges
 
 
1,190
 
 
 
1,895
 
 
 
2,884
 
 
 
2,807
 

Operating earnings
 
 
17,764
 
 
 
18,432
 
 
 
32,300
 
 
 
40,607
 

Other (expense) income:
 
 
 
 
 
 
 
 
 
 
 
 

Interest expense
 
 
(833
)
 
 
(818
)
 
 
(1,635
)
 
 
(1,512
)

Interest income
 
 
1,441
 
 
 
1,072
 
 
 
2,827
 
 
 
2,135
 

Other expense, net
 
 
(603
)
 
 
(2,606
)
 
 
(2,066
)
 
 
(2,441
)

Total other income (expense), net
 
 
5
 
 
 
(2,352
)
 
 
(874
)
 
 
(1,818
)

Earnings before income taxes
 
 
17,769
 
 
 
16,080
 
 
 
31,426
 
 
 
38,789
 

Income tax expense
 
 
3,062
 
 
 
3,183
 
 
 
5,600
 
 
 
7,548
 

Net earnings
 
$
14,707
 
 
$
12,897
 
 
$
25,826
 
 
$
31,241
 

Earnings per share:
 
 
 
 
 
 
 
 
 
 
 
 

Basic
 
$
0.48
 
 
$
0.41
 
 
$
0.84
 
 
$
0.99
 

Diluted
 
$
0.48
 
 
$
0.41
 
 
$
0.84
 
 
$
0.98
 

Basic weighted – average common shares outstanding:
 
 
30,511
 
 
 
31,488
 
 
 
30,627
 
 
 
31,560
 

Effect of dilutive securities
 
 
219
 
 
 
197
 
 
 
224
 
 
 
224
 

Diluted weighted – average common shares outstanding:
 
 
30,730
 
 
 
31,685
 
 
 
30,851
 
 
 
31,784
 

Cash dividends declared per share
 
$
0.04
 
 
$
0.04
 
 
$
0.08
 
 
$
0.08
 

CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands of dollars)

 

 
 
(Unaudited)
June 30,
2024
 
 
December 31,
2023

 

ASSETS
 
 
 
 
 
 

Current Assets
 
 
 
 
 
 

Cash and cash equivalents
 
$
161,246
 
 
$
163,876
 

Accounts receivable, net
 
 
85,380
 
 
 
78,569
 

Inventories, net
 
 
51,670
 
 
 
60,031
 

Other current assets
 
 
16,566
 
 
 
16,873
 

Total current assets
 
 
314,862
 
 
 
319,349
 

Property, plant and equipment, net
 
 
91,759
 
 
 
92,592
 

Operating lease assets, net
 
 
24,181
 
 
 
26,425
 

Other Assets
 
 
 
 
 
 

Goodwill
 
 
156,061
 
 
 
157,638
 

Other intangible assets, net
 
 
96,827
 
 
 
103,957
 

Deferred income taxes
 
 
26,619
 
 
 
25,183
 

Other
 
 
15,313
 
 
 
16,023
 

Total other assets
 
 
294,820
 
 
 
302,801
 

Total Assets
 
$
725,622
 
 
$
741,167
 

LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
 
 
 

Current Liabilities
 
 
 
 
 
 

Accounts payable
 
$
40,864
 
 
$
43,499
 

Accrued payroll and benefits
 
 
15,286
 
 
 
14,585
 

Operating lease obligations
 
 
4,371
 
 
 
4,394
 

Accrued expenses and other liabilities
 
 
31,926
 
 
 
34,561
 

Total current liabilities
 
 
92,447
 
 
 
97,039
 

Long-term debt
 
 
65,000
 
 
 
67,500
 

Long-term operating lease obligations
 
 
22,741
 
 
 
24,965
 

Long-term pension obligations
 
 
4,583
 
 
 
4,655
 

Deferred income taxes
 
 
14,314
 
 
 
14,729
 

Other long-term obligations
 
 
3,786
 
 
 
5,457
 

Total Liabilities
 
 
202,871
 
 
 
214,345
 

Commitments and Contingencies
 
 
 
 
 
 

Shareholders’ Equity
 
 
 
 
 
 

Common stock
 
 
321,894
 
 
 
319,269
 

Additional contributed capital
 
 
41,586
 
 
 
45,097
 

Retained earnings
 
 
625,614
 
 
 
602,232
 

Accumulated other comprehensive loss
 
 
775
 
 
 
4,264
 

Total shareholders’ equity before treasury stock
 
 
989,869
 
 
 
970,862
 

Treasury stock
 
 
(467,118
)
 
 
(444,040
)

Total shareholders’ equity
 
 
522,751
 
 
 
526,822
 

Total Liabilities and Shareholders’ Equity
 
$
725,622
 
 
$
741,167
 

 
 
 
 
 
 
 
 
 

CTS CORPORATION AND SUBSIDIARIES
OTHER SUPPLEMENTAL INFORMATION – UNAUDITED
(In millions of dollars, except percentages and per share amounts)

Non-GAAP Financial Measures

From time to time, CTS may use non-GAAP financial measures in discussing CTS’ business. These measures are intended to supplement, not replace, CTS’ presentation of its financial results in accordance with U.S. GAAP. CTS believes that the non-GAAP financial measures presented are commonly used by financial analysts and others in the industries in which CTS operates, and thus further provide useful information to investors. CTS’ definitions of these non-GAAP financial measures may differ from those terms as defined or used by other companies. Non-GAAP measures should not be used by investors or third parties as the sole basis for formulating investment decisions, as they may exclude a number of important cash and non-cash recurring items.

CTS has presented these non-GAAP financial measures as it believes that the presentation of its financial results that exclude (1) restructuring charges; (2) restructuring-related charges; (3) environmental charges; (4) acquisition-related costs; (5) inventory fair value step-up costs; (6) foreign exchange (gains) losses; (7) non-cash pension expenses (income); and (8) certain discrete tax items are useful and assist in comparing CTS’ current operating results with past periods and with the operational performance of other companies in its industry. Included below is a description of the expenses that CTS has determined are not normal, recurring cash operating expenses necessary to operate its business and the rationale for why providing financial measures for its business with such expenses excluded or adjusted is useful to investors as a supplement to the U.S. GAAP measures.

Restructuring charges – costs primarily related to workforce reductions, building and equipment relocations, asset impairment charges and other facility closure activities in connection with our continued optimization of our organization.
Restructuring-related charges – costs related to restructuring actions that do not qualify as direct restructuring charges under U.S. GAAP. These include duplicative expenses arising from plant consolidation transition activities such as excess rent, utilities, and personnel-related and other costs incurred prior to the start of production at a new location.
Environmental charges – costs associated with our non-operating facilities that are unrelated to ongoing operations. Currently, none of these costs and accruals relate to sites that provide revenue generating activities for the Company.
Acquisition-related costs – diligence and transaction costs related to acquisitions including related contingent earnout adjustments.
Inventory fair value step-up costs – purchase accounting-related inventory costs from acquisitions.
Foreign exchange (gains) losses – remeasurement income and expenses for non-U.S. subsidiaries with the U.S. dollar as the functional currency.
Non-cash pension expenses (income) – pension income and expenses related to the non-operating U.S. pension and post-retirement life insurance plans, including historical plan settlement activities.
Discrete tax items – non-recurring, infrequent, or unusual tax adjustments (e.g., valuation allowances, uncertain tax position changes, unremitted assertion changes and discrete impacts associated with pre-tax non-GAAP items or due to tax law changes, etc.).

At times, the reconciliations below have been intentionally rounded to the nearest thousand, or $0.01 for EPS figures, and, therefore, may not sum.

Adjusted Gross Margin

 
 
Three Months Ended
June 30,
 
 
Six Months Ended
June 30,
 
 
Twelve Months Ended
December 31,
 

 
 
2024
 
 
2023
 
 
2024
 
 
2023
 
 
2023
 
 
2022
 
 
2021
 

Gross margin
 
$
46.4
 
 
$
50.7
 
 
$
91.5
 
 
$
102.4
 
 
$
190.9
 
 
$
210.5
 
 
$
184.6
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Net sales
 
$
130.2
 
 
$
145.2
 
 
$
255.9
 
 
$
291.2
 
 
$
550.4
 
 
$
586.9
 
 
$
512.9
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Gross margin as a % of net sales
 
 
35.6
%
 
 
35.0
%
 
 
35.7
%
 
 
35.2
%
 
 
34.7
%
 
 
35.9
%
 
 
36.0
%

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Adjustments to reported gross margin:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Restructuring-related charges (b)
 
 
0.2
 
 
 

 
 
 
0.7
 
 
 

 
 
 
0.6
 
 
 

 
 
 

 

Inventory fair value step-up (b)
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 
4.0
 
 
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Adjusted gross margin
 
$
46.6
 
 
$
50.7
 
 
$
92.2
 
 
$
102.4
 
 
$
191.5
 
 
$
214.5
 
 
$
184.6
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Adjusted gross margin as a % of net sales
 
 
35.8
%
 
 
35.0
%
 
 
36.0
%
 
 
35.2
%
 
 
34.8
%
 
 
36.5
%
 
 
36.0
%


Adjusted Operating Earnings

 
 
Three Months Ended
June 30,
 
 
Six Months Ended
June 30,
 
 
Twelve Months Ended
December 31,
 

 
 
2024
 
 
2023
 
 
2024
 
 
2023
 
 
2023
 
 
2022
 
 
2021
 

Operating earnings
 
$
17.8
 
 
$
18.4
 
 
$
32.3
 
 
$
40.6
 
 
$
75.1
 
 
$
93.0
 
 
$
76.5
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Net sales
 
$
130.2
 
 
$
145.2
 
 
$
255.9
 
 
$
291.2
 
 
$
550.4
 
 
$
586.9
 
 
$
512.9
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Operating earnings as a % of net sales
 
 
13.6
%
 
 
12.7
%
 
 
12.6
%
 
 
13.9
%
 
 
13.6
%